Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langdon

Showing results (131-140 of 180) with videos related to

Pageof 18
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokinesA Wilbanks, S C Zondlo, K Murphy, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
Breast Cancer Research : BCR|January 24, 2019
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancerEdward J Jarman, Carol Ward, Arran K Turnbull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Expression of the heat shock protein HSP27 in human ovarian cancerS P Langdon, G J Rabiasz, G L Hirst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Neuregulin expression, function, and signaling in human ovarian cancer cellsLynn M R Gilmour, Kenneth G Macleod, Alison McCaig, et al.
Endocrine-Related Cancer|December 4, 2012
Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activationColette Meyer, Andrew H Sims, Kevin Morgan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1994
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell linesS P Langdon, G L Hirst, E P Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing miceJ Cummings, S P Langdon, A A Ritchie, et al.
Cells|June 12, 2014
Systems analysis of drug-induced receptor tyrosine kinase reprogramming following targeted mono- and combination anti-cancer therapyAlexey Goltsov, Yusuf Deeni, Hilal S Khalil, et al.
Pageof 18

Showing results (131-140 of 180) with videos related to

Sort By:
Pageof 18
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokinesA Wilbanks, S C Zondlo, K Murphy, et al.
Scientific Reports|December 12, 2019
Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft modelsSimon P Langdon, Charlene Kay, In Hwa Um, et al.
Breast Cancer Research : BCR|January 24, 2019
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancerEdward J Jarman, Carol Ward, Arran K Turnbull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
Expression of the heat shock protein HSP27 in human ovarian cancerS P Langdon, G J Rabiasz, G L Hirst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up studyS P Langdon, H R Hendriks, B J Braakhuis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Neuregulin expression, function, and signaling in human ovarian cancer cellsLynn M R Gilmour, Kenneth G Macleod, Alison McCaig, et al.
Endocrine-Related Cancer|December 4, 2012
Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activationColette Meyer, Andrew H Sims, Kevin Morgan, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 1, 1994
The regulation of growth and protein expression by estrogen in vitro: a study of 8 human ovarian carcinoma cell linesS P Langdon, G L Hirst, E P Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1996
Pharmacokinetics, metabolism and tumour disposition of 8-chloroadenosine 3',5'-monophosphate in breast cancer patients and xenograft bearing miceJ Cummings, S P Langdon, A A Ritchie, et al.
Cells|June 12, 2014
Systems analysis of drug-induced receptor tyrosine kinase reprogramming following targeted mono- and combination anti-cancer therapyAlexey Goltsov, Yusuf Deeni, Hilal S Khalil, et al.
Pageof 18